Medtronic Lawsuit

Medical device giant Medtronic Inc. announced recently that it had received approval from the Food and Drug Administration (FDA) to market a wire lead which will work with an implantable cardiac resynchronization device to correct irregular heart rhythms.

The new wire lead, called the Attain Starfix OTW lead, is touted by Medtronic as being a significant improvement over previous leads because it can be implanted in virtually any vein.

Problems with the Sprint Fidelis wire leads used in Medtronic implantable defibrillators has led to thousands of lawsuits from patients injured by the faulty leads. For more information, contact Medtronic lawsuit attorneys Williams Kherkher at 866-950-9000 today.